Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Beetham Thomas W. Create: Alert

All | News | Filings
Date FiledTypeDescription
12/02/2022 4 Beetham Thomas W. (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 3,000 shares @ $0.94, valued at $2.8k
08/01/2022 4 Beetham Thomas W. (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 75,000 options to buy @ $1.57, valued at $117.8k
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2022 4 Beetham Thomas W. (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 75,000 options to buy @ $3.19, valued at $239.3k
09/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2021 4 Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Converted 300,000 shares @ $0
Sold 2,477 shares @ $22.09, valued at $54.7k
Converted 300,000 options to buy @ $0
09/14/2020 4 Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 75,000 options to buy @ $15.5, valued at $1.2M
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2020 4 Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Sold 13,752 shares @ $25.07, valued at $344.8k
Exercised 13,752 options to buy @ $1.59, valued at $21.9k
04/22/2020 4 Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Sold 47,423 shares @ $19.06, valued at $903.9k
Sold 1,563 shares @ $19.56, valued at $30.6k
Sold 955 shares @ $20.44, valued at $19.5k
03/17/2020 4 Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 75,000 options to buy @ $15.52, valued at $1.2M
02/19/2020 4 Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Sold 59 shares @ $18.58, valued at $1.1k
09/19/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/06/2019 4 Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 42,000 options to buy @ $17.92, valued at $752.6k
09/24/2018 4 Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 45,000 options to buy @ $30.93, valued at $1.4M
05/29/2018 4 Beetham Thomas W. (Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Converted 6,392 shares @ $0
Bought 6,392 options to buy @ $15.6438, valued at $100k
Converted 48,172 options to buy @ $0
Converted 6,392 options to buy @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy